Temporal Profile of Serum Vitamin D Levels in Foot and Ankle Fusion Surgery

Sponsor
Prisma Health-Midlands (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04772196
Collaborator
Medical University of South Carolina (Other)
90
2
2
22.3
45
2

Study Details

Study Description

Brief Summary

Vitamin D is important for bone health and recent research has emphasized the importance of adequate vitamin D levels for bone healing, wound healing, and possibly preventing infections post-operatively. This study will assess the effect of vitamin D supplementation on patient outcomes following ankle arthrodesis or first metatarsophalangeal joint arthrodesis.

Condition or Disease Intervention/Treatment Phase
  • Drug: Vitamin D3
Early Phase 1

Detailed Description

The current status of knowledge includes preliminary research correlating hypovitaminosis, or low vitamin D status, to worse outcomes. In orthopaedic patients, vitamin D deficiency is prevalent among those scheduled to undergo surgery.

Vitamin D is important for calcium homeostasis and bone health, as well as for activation and differentiation of macrophages, dendritic cells, and lymphocytes. A recent retrospective review of outcomes in revision total joint arthroplasty patients showed that patients with low vitamin D had higher rates of postoperative complications and periprosthetic infections. Additionally, another retrospective study correlated low vitamin D levels with lower patient reported outcomes (PROs) after total hip arthroplasty. Current retrospective studies suggest that having low vitamin D levels may lead to impaired fracture healing, increased wound complication rates, and a higher risk of infections.

Given this background information, this study will investigate a series of patients undergoing ankle arthrodesis and first metatarsophalangeal joint (MTP) arthrodesis. Our study will serve to enhance the current knowledge as a level 1 randomized control study on the effect of Vitamin D supplementation on the complication rate following these two arthrodesis procedures. Our endpoints for complications will be defined as infection, wound healing complications, need for readmission, need for re-operation and nonunion as evidenced clinically and radiographically.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Patients will be randomized to receive either standard of care or supplemental Vitamin D3 following total ankle arthroplasty, ankle arthrodesis, or first metatarsophalangeal joint arthrodesis.Patients will be randomized to receive either standard of care or supplemental Vitamin D3 following total ankle arthroplasty, ankle arthrodesis, or first metatarsophalangeal joint arthrodesis.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Temporal Profile of Serum Vitamin D Levels and Outcomes After Total Ankle Arthroplasty, Ankle Arthrodesis and First Metatarsophalangeal Joint Arthrodesis
Actual Study Start Date :
Dec 21, 2020
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Nov 1, 2022

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control Group

Patients enrolled in the control group will receive standard of care.

Experimental: Vitamin D Supplementation Group

Patients enrolled in the Vitamin D Supplementation Group will receive 50,000 IU Vitamin D3 weekly for 8 weeks.

Drug: Vitamin D3
50,000 IU Vitamin D3 weekly for 8 weeks

Outcome Measures

Primary Outcome Measures

  1. Post-surgical complication rate following Vitamin D3 supplementation [6 months]

    Patients will be followed for 6 months post-operatively to determine overall complication rate in patients receiving Vitamin D3 supplementation vs. standard of care. Complications will include infection, wound healing complications, readmission, re-operation, and clinical or radiographic nonunion.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Subject is ≥ 18 years of age

  • Subject is undergoing ankle arthrodesis or MTP arthrodesis

  • Subject speaks and understands English

Exclusion Criteria:
  • Subject is < 18 years of age

  • Subject has an active joint infection

  • Subject is unable to provide consent

  • Subject is a prisoner

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical University of South Carolina Charleston South Carolina United States 29425
2 Prisma Health Columbia South Carolina United States 29203

Sponsors and Collaborators

  • Prisma Health-Midlands
  • Medical University of South Carolina

Investigators

  • Principal Investigator: Rebecca Senehi, MD, Prisma Health-Midlands

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Prisma Health-Midlands
ClinicalTrials.gov Identifier:
NCT04772196
Other Study ID Numbers:
  • Pro00095065
First Posted:
Feb 26, 2021
Last Update Posted:
Apr 22, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 22, 2022